Sales of mid- and high-priced drugs in Russia continue to decline
Sales of mid- and high-priced drugs in Russia are steadily declining, due to the ongoing economic stagnation in the country and the consequences of the financial crisis, reports The Pharma Letter’s local correspondent. According to a recent report, published by the Russian Ministry of Health, such negative trends force Russian patients to shift to cheaper…